Literature DB >> 36267787

Mismatch repair deficiency in rectal cancer: an evolving scenario.

Federico Longo1, Alfredo Carrato1,2.   

Abstract

Entities:  

Year:  2022        PMID: 36267787      PMCID: PMC9577801          DOI: 10.21037/atm-22-3529

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  9 in total

1.  Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

Authors:  Thierry André; Kai-Keen Shiu; Tae Won Kim; Benny Vittrup Jensen; Lars Henrik Jensen; Cornelis Punt; Denis Smith; Rocio Garcia-Carbonero; Manuel Benavides; Peter Gibbs; Christelle de la Fouchardiere; Fernando Rivera; Elena Elez; Johanna Bendell; Dung T Le; Takayuki Yoshino; Eric Van Cutsem; Ping Yang; Mohammed Z H Farooqui; Patricia Marinello; Luis A Diaz
Journal:  N Engl J Med       Date:  2020-12-03       Impact factor: 91.245

2.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

3.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

4.  PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.

Authors:  Andrea Cercek; Melissa Lumish; Jenna Sinopoli; Jill Weiss; Jinru Shia; Michelle Lamendola-Essel; Imane H El Dika; Neil Segal; Marina Shcherba; Ryan Sugarman; Zsofia Stadler; Rona Yaeger; J Joshua Smith; Benoit Rousseau; Guillem Argiles; Miteshkumar Patel; Avni Desai; Leonard B Saltz; Maria Widmar; Krishna Iyer; Janie Zhang; Nicole Gianino; Christopher Crane; Paul B Romesser; Emmanouil P Pappou; Philip Paty; Julio Garcia-Aguilar; Mithat Gonen; Marc Gollub; Martin R Weiser; Kurt A Schalper; Luis A Diaz
Journal:  N Engl J Med       Date:  2022-06-05       Impact factor: 176.079

5.  Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.

Authors:  Luis A Diaz; Kai-Keen Shiu; Tae-Won Kim; Benny Vittrup Jensen; Lars Henrik Jensen; Cornelis Punt; Denis Smith; Rocio Garcia-Carbonero; Manuel Benavides; Peter Gibbs; Christelle de la Fourchardiere; Fernando Rivera; Elena Elez; Dung T Le; Takayuki Yoshino; Wen Yan Zhong; David Fogelman; Patricia Marinello; Thierry Andre
Journal:  Lancet Oncol       Date:  2022-04-12       Impact factor: 54.433

6.  The prognostic and predictive value of mismatch repair status in patients with locally advanced rectal cancer following neoadjuvant therapy.

Authors:  Zehua Wu; Huabin Hu; Chao Wang; Jianwei Zhang; Yue Cai; Xiaoyu Xie; Yan Huang; Yanhong Deng
Journal:  Ann Transl Med       Date:  2022-04

Review 7.  Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes.

Authors:  Mikael Soucisse; Joseph C Kong; Michael Michael; Jeanne Tie; Samuel Y Ngan; Trevor Leong; Jacob McCormick; Satish K Warrier; Alexander G Heriot
Journal:  Ann Surg Oncol       Date:  2021-04-23       Impact factor: 5.344

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.